UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Their core work

UMH is a Spanish public university with strong research groups in neuroscience, vision science, soil and agricultural sustainability, and toxicology/endocrine disruption testing. Their neuroscience teams work on visual prosthetics, neural circuit development, and chronic pain therapies — bridging fundamental brain research with clinical applications like blindness restoration. In parallel, their environmental and health researchers contribute to EU-wide efforts on soil quality assessment, endocrine disruptor testing strategies, and plastic biodegradation. They also maintain a significant training dimension, hosting Marie Skłodowska-Curie networks that train early-stage researchers in neural crest disorders and vision restoration.

What they specialise in

How they've shifted over time

In their earlier H2020 period (2015–2018), UMH's portfolio was diverse and exploratory: robotic exoskeletons with multimodal interfaces (AIDE), soil quality assessment for agriculture (iSQAPER), cognitive manufacturing (AUTOWARE), and fundamental ERC research on blood cell biology. From 2019 onward, the portfolio sharpened toward two clear clusters — neuroscience/vision restoration (ENTRAIN VISION, NeuraViPeR, PIANO, CERCODE) and regulatory toxicology with computational approaches (GOLIATH, OBERON). The recent period also shows a growing commitment to training networks (MSCA-ITN) and a notable entry into global health through the CEAD diabetes project.

UMH is consolidating around neural prosthetics and computational toxicology — expect future proposals combining bioelectronics, imaging, and regulatory science.

How they like to work

UMH primarily operates as a contributing partner (15 of 20 projects), bringing specialized expertise to large consortia rather than leading them. Their three coordinator roles are all ERC grants — individual excellence awards rather than consortium management — which means they excel at deep research contributions but haven't built a track record of managing multi-partner projects. With 219 unique partners across 32 countries, they are well-connected and clearly open to new collaborations, functioning as a versatile research node rather than a closed-loop partner.

UMH has collaborated with 219 unique partners across 32 countries, giving them one of the broader networks for a mid-sized Spanish university. Their partnerships span the full EU geography with no obvious regional clustering beyond natural ties to other Southern European institutions.

What sets them apart

UMH's rare combination of neuroscience/vision research and environmental toxicology under one roof makes them an unusual partner — most universities specialize in one or the other. Their strength in visual prosthetics (from retinal biology to neural cortical interfaces) places them among a small group of European institutions working on blindness restoration with both fundamental and translational capacity. For consortium builders, they offer a reliable Spanish partner with ERC-level researchers who consistently deliver in multi-partner projects without demanding the coordinator seat.

Highlights from their portfolio

• BLOODCELLSCROSSTALK
  Largest single grant (EUR 1.8M ERC Starting Grant) — demonstrates capacity for independent, frontier-level research in hematology.
• CEAD
  EUR 1.2M ERC-funded project coordinated by UMH, applying implementation science to Type 2 diabetes in low-resource settings — signals global health ambitions beyond their traditional European scope.
• GOLIATH
  Major regulatory science project (EUR 673K to UMH) developing internationally harmonized testing approaches for endocrine disruptors — directly relevant to industry and policy.